SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-094026
Filing Date
2017-03-24
Accepted
2017-03-23 19:09:03
Documents
4
Period of Report
2017-03-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d345490d8k.htm 8-K 21483
2 EX-1.1 d345490dex11.htm EX-1.1 211071
3 EX-5.1 d345490dex51.htm EX-5.1 6376
4 GRAPHIC g345490g84d65.jpg GRAPHIC 2681
  Complete submission text file 0001193125-17-094026.txt   243902
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36282 | Film No.: 17710877
SIC: 2836 Biological Products, (No Diagnostic Substances)